In AD, it was more challenging to show a significant effect of KT-474 on inflammatory biomarkers in the skin, which may have had more to do with the lower basal levels of expression in the enrolled patients than with the relative roles of IRAK4 in driving inflammation in HS versus AD. The gene discussed is IRAK4; the disease is Alzheimer disease.